1 / 15

FDA Standards Development and Implementation

Pharm Toxicology Advisory Subcommittee Meeting June 10, 2003. FDA Standards Development and Implementation. Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food and Drug Administration. Overview. Standards organizations

okalani
Télécharger la présentation

FDA Standards Development and Implementation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pharm Toxicology Advisory Subcommittee Meeting June 10, 2003 FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food and Drug Administration

  2. Overview • Standards organizations • FDA Data Council, CHI, HL7, ICH, CDISC • Initiatives • Electronic submissions of applications • Clinical and non clinical study data • Annotated ECG waveform data

  3. Standards Development Organizations • Government • e.g., FDA Data Council, Consolidated Health Informatics • Accredited Standards Development Organizations (SDO) • e.g., Health Level Seven (HL7), American National Standards Institute (ANSI) • Other • e.g., ICH, CDISC

  4. FDA Data Council • FDA Data Council • Standards development for health and regulatory data and terminology for the FDA • Representatives from all agency centers and Office of the Commissioner • Standards • Involved in national and international standards development efforts

  5. Standards Development Process Centers/Offices Identify data or terminology standard need Data Council Coordinate development and promote implementation Working group of FDA experts Standard Development Organization

  6. Consolidate Health Informatics • CHI • Part of President’s eGov initiative • Set healthcare related standards for interagency use • Representatives from government agencies involved in healthcare (e.g., HHS, DoD, VA) • Standards • Use HL7 messaging standards • LOINC for laboratory tests terminology • Others related to primary health care • DICOM for transmission of radiology images • NCPDP for prescription messages • IEEE standardfor ECG monitoring messages

  7. Health Level Seven • Standards Development Organization for issues related to healthcare information • Accredited by the American National Standards Institute (ANSI) • Open, international membership • Involved in standards development activities • Health Insurance Portability and Accountability Act • National Health Information Infrastructure • Consolidated Health Informatics • Technical committees for development of FDA standards • Regulated Clinical Research Information Management • Vocabulary • Government special interest group

  8. ICH • International Conference on Harmonisation • Develop standards for communication between regulatory authorities and pharmaceutical industry • Representatives from drug regulatory authorities in the US, EU and Japan and pharmaceutical organizations (i.e., PhRMA, EFPIA and JPMA) • Standards • Common Technical Document • Electronic Common Technical Document • Individual case safety reports • MedDRA

  9. CDISC • Clinical Data Interchange Standard Consortium • Develop standards for communication of clinical trial data between pharmaceutical partners and between pharmaceutical companies and regulatory authorities • Representatives from vendors, pharmaceutical companies, CROs, industry consultants and government agencies • Standards • Submissions data model

  10. Standard Initiatives • Electronic submissions of applications • Study reports • Structured protocols • Structured Product Labeling • Individual Case Safety Report • Electronic MedWatch • Stability data • Annotated ECG waveform data • Study data

  11. Clinical and Animal Study Data • Data standards • Organization based on CDISC version 3 submission data model • Terminology • Standard procedures • Analysis tools • Repository

  12. CDISC Version 3 Submission Data Model • A study is a collection of observations • Types of observations • Interventions • Therapeutic and experimental treatments • Events • Incidences independent of planned study evaluations (e.g., adverse reactions) • Findings • Observations resulting from planned evaluationsons to address a specific question (e.g. lab test result)

  13. Standard Descriptive Variables • Observations characterized by descriptive variables • Types of descriptive variables • Topic • identifies the focus of the observation • Identifiers • identifies the subject of the observation • Timing • describes the start and end of the observation • Qualifiers • describes the traits of the observation

  14. Topic Identifier Qualifiers Timing Observations Characterized Using Standard Descriptive Variables Example Observation Subject 101A had mild nausea starting on study day 6

  15. Annotated ECG Waveform Data • Data standards • Organization based on HL7 RIM version 3 message • Information transported in XML file • Standard procedures • Viewer • Analysis tools • Repository

More Related